The
global legionella testing market is
expected to grow at a considerable rate over the forecast period owing to the
advancements and automation in the immunodiagnostic market such as the
introduction of advanced ELISA antibodies for the prevention of legionnaires
diseases in the market. The rapidly rising awareness about legionella based
diseases and the increase in demand for advanced immunodiagnostic techniques is
a direct consequence of rapidly increasing incidences of mild flu and pneumonia
like diseases through legionella bacteria. Since legionella bacteria requires
the presence of iron and cysteine to grow, it is traditionally detected by
culture on buffered charcoal yeast extract. This process takes 4 to 5 days for
detecting the legionella bacteria. The advanced immunological techniques such
as polymerase chain reaction and rapid immunological assays are efficient to
detect the legionella bacteria in few minutes. These techniques are commonly
used to establish the presence of species of Legionella bacteria in the sample.
Some of the other drivers for the growth of the global legionella testing
market include the entry of new players, new emerging economies such as China
and India and increase in the funding for healthcare facilities by the
government in many regions. There are about 40 different species of legionella
bacteria out of which 18 species are infectious. Among all these species, the
legionella pneumophilla bacterium can cause most of the diseases. Many
hospitals have started various tests such as legionella urinary antigen test
for the initial detection of legionella based diseases. This is the factor
expected to further fuel the legionella testing market over the forecast
period.
Browse Details of Report @ https://www.hexaresearch.com/upcoming-research/legionella-testing-industry
The
legionella testing market has been divided on the basis of antibiotics used for
the treatment of legionella infections into rifampin, azithromycin, ketolides,
quinolones and macrolides. It is expected that Azithromycin drug will grow at
the fastest rate throughout the forecast period owing to its efficiency to
treat legionella based diseases. Azithromycin drug is mainly used for treating
this infection in children and adults. The increasing incidences of legionella
based diseases in children and adults is also a factor driving the Azithromycin
drug segment in the market. Apart, certain flouroquinolones such as
moxifloxacin and levofloxacin are also considered as the most efficient drugs
for legionella based diseases. There are several diagnostic tests which are
available commercially in the market for initial detection of Legionella
bacteria in the body such as sputum or lung tissue test, urine antigen test,
chest X-ray and blood test. There are various end users of legionella testing
drugs which include hospitals, commercial or private labs, physician offices
and public health labs.
Major
regions estimated for the legionella testing market are North America, Europe,
Asia Pacific and RoW. As of 2013, North America dominated the market
attributing the largest share in terms of revenue. This large share can be
accounted for by the increasing number of patients suffering from legionella
based diseases, the presence of large number of market players and government
initiatives such as various public health labs across the region. Owing to the
new emerging economies such as Germany and U.K. and rising awareness about
legionella based diseases in the Europe region, it is expected that this region
will show lucrative growth in the global legionella testing market over the
forecast period.
The
key participants in the legionella testing market include Roche Diagnostics,
Beckman Coulter, Bio Rad, Novartis Diagnostics, Life Technology, Becton
Dickinson, Abott laboratories, Eiken Chemical, ID Biomedical, Thermo Fischer,
Takara Bio, Kreatech, Gen Probe, Enzo Biochem and SeraCare. The market leaders
in the global legionella testing market are involved in continuous efforts for
the development of innovative methodologies of testing which would increase the
efficiency and accuracy of test results while providing the smooth processing
of larger samples simultaneously. This companies are also entering into
strategic collaborations and expansions to extend their global patient base.
Browse Related
Category Market Reports@
About Us:
Hexa Research is a market
research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe.
We offer comprehensive business intelligence in the form of industry reports
which help our clients obtain clarity about their business environment and
enable them to undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email:
sales@hexaresearch.com
Website - http://www.hexaresearch.com/
Follow us on Linkedin: https://www.linkedin.com/company/hexa-research
drug addiction treatment
ReplyDeleteThe website is looking bit flashy and it catches the visitors eyes. Design is pretty simple and a good user friendly interface.